AU2018262108A1 - Compounds for the treatment of respiratory diseases - Google Patents

Compounds for the treatment of respiratory diseases Download PDF

Info

Publication number
AU2018262108A1
AU2018262108A1 AU2018262108A AU2018262108A AU2018262108A1 AU 2018262108 A1 AU2018262108 A1 AU 2018262108A1 AU 2018262108 A AU2018262108 A AU 2018262108A AU 2018262108 A AU2018262108 A AU 2018262108A AU 2018262108 A1 AU2018262108 A1 AU 2018262108A1
Authority
AU
Australia
Prior art keywords
compound according
mmol
compound
group
nmr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2018262108A
Other languages
English (en)
Inventor
Zalihe HAKKI
Sayali Shah
Alastair Stewart
Spencer Williams
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Melbourne
Original Assignee
University of Melbourne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2017901611A external-priority patent/AU2017901611A0/en
Application filed by University of Melbourne filed Critical University of Melbourne
Publication of AU2018262108A1 publication Critical patent/AU2018262108A1/en
Priority to AU2022202774A priority Critical patent/AU2022202774A1/en
Priority to AU2024200521A priority patent/AU2024200521B2/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU2018262108A 2017-05-03 2018-05-03 Compounds for the treatment of respiratory diseases Abandoned AU2018262108A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU2022202774A AU2022202774A1 (en) 2017-05-03 2022-04-27 Compounds for the treatment of respiratory diseases
AU2024200521A AU2024200521B2 (en) 2017-05-03 2024-01-29 Compounds for the treatment of respiratory diseases

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
AU2017901611 2017-05-03
AU2017901611A AU2017901611A0 (en) 2017-05-03 Compounds for the treatment of respiratory diseases
AU2017901647 2017-05-05
AU2017901647A AU2017901647A0 (en) 2017-05-05 Compounds for the treatment of respiratory diseases
PCT/AU2018/050404 WO2018201192A1 (en) 2017-05-03 2018-05-03 Compounds for the treatment of respiratory diseases

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2022202774A Division AU2022202774A1 (en) 2017-05-03 2022-04-27 Compounds for the treatment of respiratory diseases

Publications (1)

Publication Number Publication Date
AU2018262108A1 true AU2018262108A1 (en) 2019-11-21

Family

ID=64015663

Family Applications (3)

Application Number Title Priority Date Filing Date
AU2018262108A Abandoned AU2018262108A1 (en) 2017-05-03 2018-05-03 Compounds for the treatment of respiratory diseases
AU2022202774A Abandoned AU2022202774A1 (en) 2017-05-03 2022-04-27 Compounds for the treatment of respiratory diseases
AU2024200521A Active AU2024200521B2 (en) 2017-05-03 2024-01-29 Compounds for the treatment of respiratory diseases

Family Applications After (2)

Application Number Title Priority Date Filing Date
AU2022202774A Abandoned AU2022202774A1 (en) 2017-05-03 2022-04-27 Compounds for the treatment of respiratory diseases
AU2024200521A Active AU2024200521B2 (en) 2017-05-03 2024-01-29 Compounds for the treatment of respiratory diseases

Country Status (9)

Country Link
US (2) US20200079757A1 (cg-RX-API-DMAC7.html)
EP (1) EP3619204B1 (cg-RX-API-DMAC7.html)
JP (2) JP7788128B2 (cg-RX-API-DMAC7.html)
CN (1) CN110753688A (cg-RX-API-DMAC7.html)
AU (3) AU2018262108A1 (cg-RX-API-DMAC7.html)
ES (1) ES3049333T3 (cg-RX-API-DMAC7.html)
FI (1) FI3619204T3 (cg-RX-API-DMAC7.html)
PT (1) PT3619204T (cg-RX-API-DMAC7.html)
WO (1) WO2018201192A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016149756A1 (en) 2015-03-23 2016-09-29 The University Of Melbourne Treatment of respiratory diseases
AU2019374731B2 (en) * 2018-11-07 2025-08-21 Tianli Biotech Pty Ltd Compounds and compositions for the treatment of respiratory diseases
CN110452880B (zh) * 2019-09-09 2021-09-21 温州医科大学附属第一医院 急性肺损伤细胞模型的制备方法及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5593991A (en) * 1993-07-16 1997-01-14 Adams; Jerry L. Imidazole compounds, use and process of making
US5593992A (en) * 1993-07-16 1997-01-14 Smithkline Beecham Corporation Compounds
IL110296A (en) * 1993-07-16 1999-12-31 Smithkline Beecham Corp Imidazole compounds process for their preparation and pharmaceutical compositions containing them
IL118544A (en) * 1995-06-07 2001-08-08 Smithkline Beecham Corp History of imidazole, the process for their preparation and the pharmaceutical preparations containing them
JP2001526230A (ja) * 1997-12-19 2001-12-18 スミスクライン・ビーチャム・コーポレイション ヘテロアリール置換イミダゾール化合物、その医薬組成物および使用
MX2012004997A (es) * 2009-10-28 2012-06-12 Pfizer Derivados de imidazol como inhibidores de la caseina quinasa.
CZ2012538A3 (cs) * 2012-08-08 2014-02-19 Masarykova Univerzita Inhibitory pro léčbu B-buněčné chronické lymfocytární leukémie
WO2016149756A1 (en) 2015-03-23 2016-09-29 The University Of Melbourne Treatment of respiratory diseases

Also Published As

Publication number Publication date
JP7788128B2 (ja) 2025-12-18
JP2023134493A (ja) 2023-09-27
JP2020518621A (ja) 2020-06-25
US20200079757A1 (en) 2020-03-12
EP3619204A1 (en) 2020-03-11
PT3619204T (pt) 2025-10-29
CN110753688A (zh) 2020-02-04
AU2024200521B2 (en) 2025-10-02
EP3619204A4 (en) 2021-03-24
AU2024200521A1 (en) 2024-02-15
US20220380343A1 (en) 2022-12-01
EP3619204B1 (en) 2025-10-01
AU2022202774A1 (en) 2022-05-19
WO2018201192A1 (en) 2018-11-08
ES3049333T3 (en) 2025-12-16
FI3619204T3 (fi) 2025-11-06

Similar Documents

Publication Publication Date Title
US11975005B2 (en) Treatment of respiratory diseases
EP3877382B1 (en) Novel compounds for the treatment of respiratory diseases
US20220380343A1 (en) Compounds for the treatment of respiratory diseases
US20130164280A1 (en) Pyrazolo[1,5-a]pyrimidines as antiviral agents
CN111620815B (zh) 手性氯喹、羟氯喹和其衍生物及其制备方法与用途
HK40023875A (en) Compounds for the treatment of respiratory diseases
HK40023875B (en) Compounds for the treatment of respiratory diseases
HK40059876A (en) Treatment of respiratory diseases
HK40058742A (en) Treatment of respiratory diseases

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted